Press Releases

September 9, 2024

Pharmaceutical Technology 2024 Excellence Awards Honor BSI as Dual Category Award Winner

August 20, 2024

Botanical Solution Inc. (BSI) Series A extended to over $23 Million

November 8, 2023

Botanical Solution Inc. (BSI) Wins 2023 Best Product/Service of the Year Award at UK’s Big Sustainability Award Competition

October 23, 2023

Botanical Solution Inc. (BSI) Wins ICIS Chemical Business 2023 Best Process Innovation Award

May 22, 2023

Croda and BSI announce partnership to accelerate production of sustainable vaccine adjuvant QS-21

November 17, 2022

Quillibrium® Wins Crop Science Award for “Best New Biological Product (Biopesticide)”

October 18, 2022

Botanical Solution Inc. (BSI) ‘Finalist’ for “Best Industry Collaboration with Syngenta” in Crop Science Awards

May 26, 2022

BSI Wins Best Biotech Startup Business of the Year 2022 Award

January 17, 2022

BSI Secures $6.1 Million in Series A First Closing

March 9, 2021

New Botanical-Based Biofungicide Expanding Distribution Under Strong Partnership Between BSI and Syngenta

February 16, 2021

A Sustainable Future With QS-21, the ‘Gold Standard’ of Human Immune System Activators for COVID-19 and Other Vaccines Featured at 2021 BIO CEO & Investor Conference

December 23, 2020

BSI Secures $3.3 Million in Funding with Second Round Planned for Spring 2021

September 1, 2020

BSI Appoints Marcus Meadows-Smith to their Board